Hemovent (Aachen, Germany) recently announced that it has received CE Mark approval for its Mobybox ECLS System.
Mobybox is a miniature heart/lung machine that uses the company’s Bionique Flow Technologies platform. It is a self-contained and fully-integrated ExtraCorporeal Life Support system that is designed for ease of use, mobility and high performance to support or replace heart and lunch function in cardiac and respiratory failure.
“We will commence immediately with the roll-out of our initial product Mobybox in a phased approach among various centers of excellence in Europe,” co-founder and CEO Christof Lenz said in a press release. “Given our recent announcement of the closing of our Series B financing round, we have the financial resources in place to be immediate and steadfast in executing our product launch.”
The system features a pneumatic drive line that allows the system to be easily separated from the patient unit controller.
“Imagine simplifying critical care treatment for millions of people with a device that can fit into a backpack,” Oliver Marseille, chief technology officer, said. “Mobybox is designed to make high-end critical care for heart and lung support much safer and simpler to use. In doing so, Mobybox has the potential to help more than two million patients worldwide annually who suffer from acute cardiac and respiratory failure.”
